Biotech Acquisition Co Stock Return On Asset
| BIOTDelisted Stock | USD 10.15 0.00 0.00% |
Biotech Acquisition Co fundamentals help investors to digest information that contributes to Biotech Acquisition's financial success or failures. It also enables traders to predict the movement of Biotech Stock. The fundamental analysis module provides a way to measure Biotech Acquisition's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Biotech Acquisition stock.
Biotech |
Biotech Acquisition Co Company Return On Asset Analysis
Biotech Acquisition's Return on Asset or ROA shows how effective is the management of the company in generating income from utilizing all of the assets at their disposal. It is a useful ratio to evaluate the performance of different departments of a company as well as to understand management performance over time.
Current Biotech Acquisition Return On Asset | -0.0085 |
Most of Biotech Acquisition's fundamental indicators, such as Return On Asset, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Biotech Acquisition Co is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Return on Asset measures overall efficiency of a company in generating profits from its total assets. It is expressed as the percentage of profits earned per dollar of Asset. A low ROA typically means that a company is asset-intensive and therefore will needs more money to continue generating revenue in the future.
CompetitionBased on the latest financial disclosure, Biotech Acquisition Co has a Return On Asset of -0.0085. This is 98.19% lower than that of the Financial Services sector and significantly lower than that of the Shell Companies industry. The return on asset for all United States stocks is 93.93% lower than that of the firm.
Biotech Return On Asset Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Biotech Acquisition's direct or indirect competition against its Return On Asset to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Biotech Acquisition could also be used in its relative valuation, which is a method of valuing Biotech Acquisition by comparing valuation metrics of similar companies.Biotech Acquisition is currently under evaluation in return on asset category among its peers.
Biotech Fundamentals
| Return On Asset | -0.0085 | |||
| Current Valuation | 290.09 M | |||
| Shares Outstanding | 23 M | |||
| Shares Owned By Institutions | 100.00 % | |||
| Number Of Shares Shorted | 9.3 K | |||
| Price To Earning | 29.21 X | |||
| Price To Book | 1.33 X | |||
| EBITDA | (6.86 M) | |||
| Net Income | (6.86 M) | |||
| Cash And Equivalents | 1.7 K | |||
| Total Debt | 153.35 K | |||
| Debt To Equity | 3.48 % | |||
| Current Ratio | 0.04 X | |||
| Book Value Per Share | (0.46) X | |||
| Cash Flow From Operations | (1.47 M) | |||
| Short Ratio | 0.05 X | |||
| Earnings Per Share | 0.26 X | |||
| Market Capitalization | 291.81 M | |||
| Total Asset | 230 | |||
| Net Asset | 230 |
About Biotech Acquisition Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Biotech Acquisition Co's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Biotech Acquisition using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Biotech Acquisition Co based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Thematic Opportunities
Explore Investment Opportunities
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in persons. You can also try the Portfolio File Import module to quickly import all of your third-party portfolios from your local drive in csv format.
Other Consideration for investing in Biotech Stock
If you are still planning to invest in Biotech Acquisition check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Biotech Acquisition's history and understand the potential risks before investing.
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance |